Amylin Pharmaceuticals
San Diego · Founded 1987
About Amylin Pharmaceuticals
Amylin Pharmaceuticals is a biopharmaceutical company, engages in the discovery, development, and commercialization of drugs. Develops a line of diagnostic and therapeutic products for diabetics. Working towards a cure for diabetes by challenging science, changing lives. Amylin employees are dedicated in their ability to "think outside the box". Because of our commitment of constantly finding newer and better ways to treat diabetes, we come to work each day feeling like we CAN make a difference in our world.
Company Facts
- Founded: 1987
- Operating status: Active
- Company type: For Profit
- IPO status: Delisted
- Employees: 5,001 – 10,000
- Funding stage: M&A
- Last round: Series Unknown (Jan 1990)
- Ticker: nasdaq:AMLN
- Website: amylin.com
- Phone: (858) 552-2200
Industries & Categories
Biotechnology
Social Profiles
Canonical: https://fsome.com/organization/amylin-pharmaceuticals-1918128 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.